ArticleBMC infectious diseases2026
Infection or contamination - Clinical attribution of blood culture-positive episodes in neonatal intensive care: an 11-year retrospective single-center study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPositive blood cultures in neonatal intensive care do not necessarily indicate clinically relevant bloodstream infection. Interpretation is particularly challenging for coagulase-negative staphylococci (CoNS), which may represent either contamination or clinically relevant infection depending on the clinical context. We aimed to describe how treating teams attributed culture-positive episodes as infection or contamination in routine neonatal care and to examine which clinical, laboratory, and microbiological features were associated with this original clinical attribution. As a secondary aim, we characterized the local epidemiology of culture-positive episodes.
methodsWe conducted a retrospective single-center study of all culture-positive episodes occurring between 2014 and 2024 in neonates hospitalized in a German tertiary NICU at the time of blood culture sampling. Original clinical attribution was extracted from documentation recorded during the index episode. Descriptive analyses and exploratory logistic regression were performed.
resultsAmong 3246 blood cultures, 232 (7.1%) were positive. After accounting for additional follow-up and parallel cultures and other exclusions, 189 unique culture-positive episodes remained for analysis; 125 (66.1%) were attributed as infection and 64 (33.9%) as contamination. Thirty-five episodes (18.5%) occurred during the early-onset period and 154 (81.5%) during the late-onset period. Coagulase-negative staphylococci (CoNS) were detected in 114 episodes (60.3%) and showed the greatest variability in attribution. All 13 CoNS-positive early-onset episodes were attributed as contamination, whereas 64 of 101 CoNS-positive late-onset episodes (63.4%) were attributed as infection. Enterobacterales, Enterococcus faecalis, Staphylococcus aureus, and Candida spp. were almost uniformly attributed as infection, whereas Bacillus spp. and environmental organisms were predominantly attributed as contamination. In late-onset episodes, maximum CRP showed the strongest association with attribution as infection in univariable and multivariable analyses (adjusted OR 4.41, 95% CI 2.59-7.51). Associations with time-to-positivity, CoNS detection, and central vascular catheter presence were weaker and imprecisely estimated after adjustment.
conclusionsClinical attribution of culture-positive episodes was associated with the combined consideration of organism plausibility, inflammatory response, time-to-positivity, and clinical context. CoNS-positive late-onset episodes represented the greatest diagnostic uncertainty. These findings describe real-world clinical attribution rather than diagnostic accuracy and underline the need for more reproducible criteria to support antimicrobial stewardship without compromising the treatment of vulnerable neonates.
Indexed as
Identifiers
42888396What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.